Cargando…
Moderate to severe HIV-associated neurocognitive impairment: A randomized placebo-controlled trial of lithium
BACKGROUND: HIV-associated neurocognitive disorder (HAND) remains highly prevalent despite effective anti-retroviral therapy (ART). A number of adjunctive pharmacotherapies for HAND have been studied with disappointing results, but preliminary data suggest that lithium may provide clinical benefit....
Autores principales: | Decloedt, Eric H., Freeman, Carla, Howells, Fleur, Casson-Crook, Martine, Lesosky, Maia, Koutsilieri, Eleni, Lovestone, Simon, Maartens, Gary, Joska, John A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5120936/ https://www.ncbi.nlm.nih.gov/pubmed/27861379 http://dx.doi.org/10.1097/MD.0000000000005401 |
Ejemplares similares
-
Blood and cerebrospinal fluid biomarker changes in patients with HIV-associated neurocognitive impairment treated with lithium: analysis from a randomised placebo-controlled trial
por: Thela, Lindokuhle, et al.
Publicado: (2023) -
Renal safety of lithium in HIV-infected patients established on tenofovir disoproxil fumarate containing antiretroviral therapy: analysis from a randomized placebo-controlled trial
por: Decloedt, Eric H., et al.
Publicado: (2017) -
Neurocognitive development in HIV-positive children is correlated with plasma viral loads in early childhood
por: Weber, Valentin, et al.
Publicado: (2017) -
HIV-related neurocognitive disorders: Diagnosis, Treatment, and Mental Health Implications: A Review
por: Elendu, Chukwuka, et al.
Publicado: (2023) -
Simulating therapeutic drug monitoring results for dose individualisation to maintain investigator blinding in a randomised controlled trial
por: Lesosky, Maia, et al.
Publicado: (2017)